Document Detail


Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PET.
MedLine Citation:
PMID:  21106723     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: We apply positron emission tomography (PET) to elucidate changes in nanocarrier extravasation during the transition from premalignant to malignant cancer, providing insight into the use of imaging to characterize early cancerous lesions and the utility of nanoparticles in early disease.
EXPERIMENTAL DESIGN: Albumin and liposomes were labeled with (64)Cu (half-life 12.7 hours), and longitudinal PET and CT imaging studies were conducted in a mouse model of ductal carcinoma in situ. A pharmacokinetic model was applied to estimate the tumor vascular volume and permeability.
RESULTS: From early time points characterized by disseminated hyperproliferation, the enhanced vascular permeability facilitated lesion detection. During disease progression, the vascular volume fraction increased 1.6-fold and the apparent vascular permeability to albumin and liposomes increased ∼2.5-fold to 6.6 × 10(-8) and 1.3 × 10(-8) cm/s, respectively, with the accumulation of albumin increasing earlier in the disease process. In the malignant tumor, both tracers reached similar mean intratumoral concentrations of ∼6% ID/cc but the distribution of liposomes was more heterogeneous, ranging from 1% to 18% ID/cc compared with 1% to 9% ID/cc for albumin. The tumor-to-muscle ratio was 17.9 ± 8.1 and 7.1 ± 0.5 for liposomes and albumin, respectively, indicating a more specific delivery of liposomes than with albumin.
CONCLUSIONS: PET imaging of radiolabeled particles, validated by confocal imaging and histology, detected the transition from premalignant to malignant lesions and effectively quantified the associated changes in vascular permeability.
Authors:
Cecilie B Rygh; Shengping Qin; Jai W Seo; Lisa M Mahakian; Hua Zhang; Roger Adamson; Jane Q Chen; Alexander D Borowsky; Robert D Cardiff; Rolf K Reed; Fitz-Roy E Curry; Katherine W Ferrara
Related Documents :
19687763 - Evaluation of (18)f-fdg pet-ct for differentiation of pulmonary pathology in an approac...
16987763 - Ocular adnexal langerhans cell histiocytosis clinical features and management.
16786573 - Dynamic mr perfusion and proton mr spectroscopic imaging in sturge-weber syndrome: corr...
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-11-24
Journal Detail:
Title:  Clinical cancer research : an official journal of the American Association for Cancer Research     Volume:  17     ISSN:  1078-0432     ISO Abbreviation:  Clin. Cancer Res.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-03     Completed Date:  2011-06-17     Revised Date:  2012-03-14    
Medline Journal Info:
Nlm Unique ID:  9502500     Medline TA:  Clin Cancer Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  550-9     Citation Subset:  IM    
Copyright Information:
©2010 AACR.
Affiliation:
Department of Physiology and Membrane Biology, University of California Davis, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Capillary Permeability*
Carcinoma in Situ / blood supply*
Cell Transformation, Neoplastic / metabolism*
Copper Radioisotopes / diagnostic use
Disease Progression
Liposomes / metabolism*
Mammary Neoplasms, Experimental / blood supply*
Mice
Nanoparticles / analysis
Positron-Emission Tomography / methods*
Serum Albumin / metabolism
Grant Support
ID/Acronym/Agency:
K26 RR024037-05/RR/NCRR NIH HHS; R01 CA103828-06A1/CA/NCI NIH HHS; R01 CA103828-07/CA/NCI NIH HHS; R01 CA103828-08/CA/NCI NIH HHS; R01 CA103828-09/CA/NCI NIH HHS; R01 CA134659-01A1/CA/NCI NIH HHS; R01 CA134659-02/CA/NCI NIH HHS; R01 CA134659-03/CA/NCI NIH HHS; R01 CA134659-04/CA/NCI NIH HHS; R01CA103828/CA/NCI NIH HHS; R01CA134659/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Copper Radioisotopes; 0/Liposomes; 0/Serum Albumin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit ...
Next Document:  Impact of ABCB1 allelic variants on QTc interval prolongation.